For the year ending 2025-12-31, WST has $4,270,000K in assets. $1,094,000K in debts. $791,300K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 791,300 | 484,600 | 853,900 | 894,300 |
| Accounts receivable, net | 574,400 | 552,500 | 512,000 | 507,400 |
| Inventories | 443,900 | 377,000 | 434,700 | 414,800 |
| Other current assets | 168,600 | 124,000 | 135,800 | 103,000 |
| Total current assets | 1,978,200 | 1,538,100 | 1,936,400 | 1,919,500 |
| Property, plant and equipment | 3,223,400 | 2,985,800 | 2,738,000 | 2,386,600 |
| Less accumulated depreciation and amortization | 1,497,000 | 1,404,200 | 1,324,700 | 1,228,300 |
| Property, plant and equipment, net | 1,726,400 | 1,581,600 | 1,413,300 | 1,158,300 |
| Operating lease right-of-use assets | 117,000 | 104,500 | 99,200 | 104,400 |
| Investments in affiliated companies | 212,300 | 202,100 | 210,000 | 204,900 |
| Goodwill | 109,900 | 106,000 | 108,500 | 107,300 |
| Intangible assets, net | 7,700 | 10,800 | 15,100 | 18,400 |
| Deferred income taxes | 38,400 | 26,000 | 25,700 | 65,600 |
| Pension and other postretirement benefits | - | - | - | 300 |
| Other noncurrent assets | 80,100 | 74,300 | 21,300 | 38,100 |
| Total assets | 4,270,000 | 3,643,400 | 3,829,500 | 3,616,800 |
| Notes payable and other current debt | - | 0 | 134,000 | 2,200 |
| Accounts payable | 253,700 | 239,300 | 242,400 | 215,400 |
| Pension and other postretirement benefits | - | - | - | 2,100 |
| Accrued salaries, wages and benefits | 135,900 | 73,500 | 105,900 | 76,800 |
| Income taxes payable | 28,100 | 31,500 | 16,600 | 24,800 |
| Operating lease liabilities | 22,700 | 17,900 | 17,700 | 16,000 |
| Other current liabilities | 214,500 | 188,200 | 155,200 | 181,700 |
| Total current liabilities | 654,900 | 550,400 | 671,800 | 519,000 |
| Long-term debt | 202,800 | 202,600 | 72,800 | 206,700 |
| Deferred income taxes | 23,000 | 20,500 | 12,700 | 14,300 |
| Pension and other postretirement benefits | 29,000 | 28,200 | 29,600 | 28,200 |
| Operating lease liabilities | 95,600 | 81,800 | 84,500 | 93,000 |
| Deferred compensation benefits | 13,500 | 15,400 | 18,600 | 19,100 |
| Other long-term liabilities | 75,200 | 62,200 | 58,500 | 51,600 |
| Total liabilities | 1,094,000 | 961,100 | 948,500 | 931,900 |
| Common stock, par value 0.25 per share 200 million shares authorized shares issued 75.3 million in 2025 and 2024 shares outstanding 72.0 million and 72.3 million in 2025 and 2024 | 18,800 | 18,800 | 18,800 | 18,800 |
| Capital in excess of par value | 0 | 22,100 | 120,200 | 232,200 |
| Retained earnings | 4,374,900 | 3,956,600 | 3,523,400 | 2,987,800 |
| Accumulated other comprehensive loss | -105,500 | -258,100 | -143,800 | -183,000 |
| Treasury stock, at cost (1.2 million and 1.1 million shares in 2022 and 2021) | - | - | - | 370,900 |
| Treasury stock, at cost (3.3 million and 3.0 million shares in 2025 and 2024) | 1,112,200 | 1,057,100 | 637,600 | - |
| Total equity | 3,176,000 | 2,682,300 | 2,881,000 | 2,684,900 |
| Total liabilities and equity | 4,270,000 | 3,643,400 | 3,829,500 | 3,616,800 |
WEST PHARMACEUTICAL SERVICES INC (WST)
WEST PHARMACEUTICAL SERVICES INC (WST)